Research on gut microbiome effects on pediatric diseases
Official title: Prediction and Treatment of Pediatric Diseases and Long-term Outcomes Through Microbiome and Multi-Omics Study by Life Cycle
Run by Hanyang University · NCT06812091 · Data updated 2026-11-12
This study is testing how changes in the gut bacteria of children, including newborns, might be linked to different health issues to better understand their impact on long-term health.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Hanyang University Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | January 1, 2026 |
| Study ends | January 1, 2030 |
| Registry record updated | February 6, 2025 |
| Trial ID | NCT06812091 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children, including newborns, whose guardians have provided consent.
✕Probably not a fit
Patients who do not have consent from their guardians will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between gut microbiome dysbiosis and various pediatric diseases by analyzing fecal samples from children, including newborns. It employs high-throughput sequencing and multi-omics analyses to categorize children into disease groups and assess changes in their microbiome over time. The research aims to provide insights into the gut-lung and gut-brain axes and how these interactions affect long-term health outcomes in children.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of pediatric diseases linked to gut microbiome imbalances.
How similar studies have gone: Other studies have shown promising results in understanding the microbiome's role in health, suggesting potential for success in this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * children (including newborns) who have obtained their consent from their guardians Exclusion Criteria: * subjects who did not obtain consent
Where it's running
-
Hanyang University Medical Center
Seoul, South Korea Recruiting
Study contacts
- Principal investigator: Hyun-Kyung Park, MD — Hanyang University
- Study coordinator: Hyun-Kyung Park, MD
- Email: neopark@hanyang.ac.kr
- Phone: 82-10-4749-1454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Azithromycin for treating non-bloody Shigella watery diarrhea in children
It will test whether giving azithromycin to children 6–59 months with Shigella-positive watery (non-bloody) diarrhea shortens the illness, clears the bacteria faster, and improves growth.
-
Effectiveness of a Counseling Program to Support Exclusive Breastfeeding
A counseling program is tested to see if it helps new mothers in a primary care setting breastfeed exclusively for six months.
-
MRI-measured neural flexibility development in Chinese toddlers aged 32–42 months
This project will use MRI and parent-rated tests to see if neural flexibility and executive function differ in typically developing Chinese toddlers aged 32–42 months, including groups fed S-26 GOLD/ULTIMA GUM versus cow's milk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.